RenalTransplant near Jersey City, NJ

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

Biography: Dr. Daniel Sagalovich, MD is an Urology Specialist who practices in Staten Island, NY. He is 40 years old and has been practicing for 13 years. Dr. Daniel Sagalovich, MD is affiliated with Staten Island University Hospital.

Biography: James McKiernan, MD, is the John K. Lattimer Professor of Urology, and CEO, of ColumbiaDoctors. He also is the interim dean of Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues. For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer.

Biography: Christopher B. Anderson, MD, Associate Professor of Urology at CUMC, joined the Department of Urology in September 2015. He specializes in cancers of the bladder, prostate, kidney, testis and penis and performs both open and robotic surgeries. Dr. Anderson completed his medical degree from Northwestern University, completed his urology residency at Vanderbilt University, and then spent two years at Memorial Sloan Kettering Cancer Center as a fellow in urologic oncology. Following his residency, Dr. Anderson completed a urologic oncology fellowship at Memorial Sloan Kettering Cancer Center and obtained a Master of Public Health degree from Harvard University. Dr. Anderson's research interests include factors that influence the quality of surgery, access to care for patients with bladder cancer, outcomes after robotic prostatectomy, and active surveillance strategies for men with prostate cancer. Dr. Anderson has published several peer-reviewed articles and was recognized as "Best Reviewer" in 2014 by The Journal of Urology and in 2016 by Cancer. Dr. Anderson has clinical expertise in robotic prostatectomy for the treatment of prostate cancer, radical cystectomy with orthotopic neobladder for patients with bladder cancer, and partial nephrectomy for the treatment of kidney tumors. He also specializes in the multidisciplinary management of men with testicular cancer, including the use of primary and post-chemotherapy retroperitoneal lymph node dissection. He is currently the site leader for several clinical trials investigating the use of immunotherapy in patients with invasive and non-invasive bladder cancer.

Biography: Dr. Peter Liou is an Assistant Professor of Surgery at Columbia University and an Attending Transplant Surgeon at New York Presbyterian Hospital. He is board-certified in general surgery and received specialty training in abdominal transplant and hepatobiliary surgery. His practice interests focus on the surgical management of adults and children with liver and bile duct disease including those with liver failure, cirrhosis, bile duct and gallbladder disease, as well as those with benign and malignant liver tumors and cysts. He is skilled in minimally invasive surgery and trained to perform both laparoscopic and robotic surgery whenever possible. Dr. Liou received his Bachelor of Arts degree in Biochemistry and Music from Columbia College, and subsequently attended medical school at Columbia University's College of Physicians and Surgeons. He was the recipient of a Doris Duke Translational Research Grant under the mentorship of Dr. Jessica Kandel. Dr. Liou then completed his general surgical residency at New York Presbyterian / Columbia, while receiving additional clinical training in Intestinal/Multivisceral transplant and Adult ECMO with Drs. Tomoaki Kato and Matthew Bacchetta during that time. He then continued with a surgical fellowship in Abdominal Organ Transplantation and Hepatobiliary Surgery at New York Presbyterian Columbia and Weill Cornell. Committed to providing compassionate and the latest comprehensive care, Dr. Liou routinely collaborates with an elite team of world-class providers in liver disease to achieve optimal outcomes and treatment success. He is also interested in international medicine, having participated in surgical outreaches and exchanges in China, Kenya, Swaziland, and Tanzania.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Biography: Dr. Daniel Herron, MD is a Bariatric Surgery Specialist who practices in New York, NY. He is 60 years old and has been practicing for 33 years. Dr. Daniel Herron, MD is affiliated with Mount Sinai Hospital and Mount Sinai Queens.